Fidelity Sale Of Donated Funds Was 'Nightmare,' Judge Hears

Law360, San Francisco (October 21, 2020, 10:21 PM EDT) -- Fidelity Investments' charitable arm engaged in the "reckless sale" of donated stock that caused a multimillion-dollar loss in value, a philanthropist testified during a California federal bench trial Wednesday, saying the sale was her "worst nightmare" and that Fidelity must restore the money earmarked for a Lyme disease charity to make things right.

"I was beyond horrified and I was very sad," philanthropist and former hedge fund manager Emily Fairbairn said during her at times emotional testimony, explaining that her family was passionate about making a $100 million donation to support research into Lyme disease, a tick-borne disease that had afflicted...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!